Microbiología

2022

1. A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice

   Vaccines, Vol. 10, Núm. 6

2. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity

   Environmental Research, Vol. 210

3. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

   The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 10, pp. 2809-2815

4. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials

   The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281

5. Antimicrobial Activity of Polyphenols and Natural Polyphenolic Extracts on Clinical Isolates

   Antibiotics, Vol. 11, Núm. 1

6. Antimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula

   Marine Drugs, Vol. 20, Núm. 5

7. Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales

   Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 2

8. Biotecnología para el diagnóstico, tratamiento y prevención de las enfermedades infecciosas en acuicultura

   SEM@foro, Núm. 74, pp. 53-54

9. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

   Frontiers in Microbiology, Vol. 13

10. Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species

    Microbiology Spectrum, Vol. 10, Núm. 1

11. Case report: BA.1 subvariant showing a BA.2-like pattern using a variant-specific PCR assay due to a single point mutation downstream the spike 69/70 deletion

    Virology Journal, Vol. 19, Núm. 1

12. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

13. Cerebrospinal fluid drainage-related ventriculitis due to multidrug-resistant microorganisms

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 6, pp. 322-325

14. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients

    Scientific Reports, Vol. 12, Núm. 1

15. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

16. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

17. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

    PLoS ONE, Vol. 17, Núm. 7 July

18. Clostridioides difficile toxin B gen amplification cycle threshold as a predictor of severity

    Revista Chilena de Infectologia, Vol. 39, Núm. 1, pp. 29-34

19. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

20. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10